David Ewing Duncan

Guest Speaker at Singularity University

Schools

  • Singularity University

Links

Biography

Singularity University

David Ewing Duncan is an award-winning, best-selling author of eight books and numerous essays, articles and short stories; and a television, radio and film producer and correspondent. He is a Correspondent for Atlantic.com ; he is also the Chief Correspondent for public radio Biotech Nation, heard on NPR Talk. He writes for the New York Times, Fortune, Wired, Discover, Atlantic, National Geographic, and many other publications. At UC Berkeley he is the Founding Director of the Center for Life Science Policy. David most recent book is When 164: The new science of radical life extension, and what happens if it succeeds (TED Books). He also wrote the bestselling Experimental Man: What one man body reveals about his future, your health, and our toxic world (Wiley). His previous book was Masterminds: Genius, DNA and the Quest to Rewrite Life (Harper Perennial). He wrote the international bestseller Calendar: Humanity Epic Struggle to Determine a True and Accurate Year (Harper-Collins/Avon), published in 19 languages, and a bestseller in 14 countries. David has been a Contributing Editor and columnist for Conde Nast Portfolio, and a Contributing Editor for Wired, Discover and MIT Technology Review; he has been a longtime commentator for NPR Morning Edition, and a special correspondent and producer for ABC Nightline and 20/20. He has been a correspondent for NOVA ScienceNow!, and a producer for Discovery Television. He has written for Harper, Atlantic Monthly, Smithsonian, Outside, The Telegraph, The Guardian, The Washington Post Book World, The San Francisco Chronicle, and The New York Times, among others. In 2003, David won the prestigious Magazine Story of the Year Award from the American Association for the Advancement of Science. His articles have twice been cited in nominations for National Magazine Awards, and his work has appeared twice in The Best American Science and Nature Writing.

David is the Founder and Editorial Director of the BioAgenda Institute, an independent, non-profit program of events and educational initiatives that discusses and analyzes crucial issues in life sciences which is being folded into the new Center for Life Science Policy at UC Berkeley. He has been the host of the annual BioAgenda Summit. David other books include the bestselling Pedaling the Ends of the Earth (Simon & Schuster), about his bicycle expedition around the world, and Hernando Soto: A Savage Quest in the Americas, called an astonishing tour de force by the New York Times Book Review. He wrote Residents: The Perils and Promise of Educating Young Doctors (Scribner) and Cape to Cairo: An African Odyssey (Grove Atlantic). His fiction has appeared in two anthologies. He has taught creative writing at Stanford University. He works at the San Francisco Writer Grotto, and lives in San Francisco.

Expertise

  • Health Innovation
  • Medicine

Read about executive education

Other experts

Yvonne Cagle

Dr. Yvonne Darlene Cagle is an astronaut for the National Aeronautics and Space Administration (NASA), and consulting professor for Stanford University’s department of cardiovascular medicine and its department of electrical engineering. In addition, Dr. Cagle also has served as a certified senio...

Eric Koester

Eric Koester is a serial entrepreneur. He has spent much of his career building companies, working with entrepreneurs and writing and teaching around topics of customer discovery, lean, entrepreneurship and innovation. Eric is currently the founder of Main Street Genome, a new technology startup ...

Arthur Rubenstein

Dr. Arthur H. Rubenstein is Professor, Department of Medicine, Division of Endocrinology at the Perelman School of Medicine at the University of Pennsylvania. Previously, he was the Executive Vice President for the Health System and Dean of the Perelman School of Medicine from September 2001 to J...

Looking for an expert?

Contact us and we'll find the best option for you.

Something went wrong. We're trying to fix this error.